🔴 Eupraxia Pharmaceuticals is trading 5.9% down with broad-market sell-off the likeliest context

Eupraxia Pharmaceuticals is trading at $6.36, down 5.92%, with the broad-market sell-off the likeliest context for the decline.

• No clear company-specific announcement explaining the November 5 decline surfaced in the search; the latest identified release announced upcoming conference appearances and an analyst day.
• The move coincides with a sharp broad-market sell-off, though healthcare-sector strength makes that attribution less certain.
• Trading volume and activity level were not available in the supplied context.